tiprankstipranks
Trending News
More News >
Carisma Therapeutics (CARM)
OTHER OTC:CARM
US Market

Carisma Therapeutics (CARM) Ratios

Compare
1,722 Followers

Carisma Therapeutics Ratios

CARM's free cash flow for Q3 2025 was $1.00. For the 2025 fiscal year, CARM's free cash flow was decreased by $ and operating cash flow was $0.99. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Dec 21
Liquidity Ratios
Current Ratio
0.86 1.48 5.06 2.78 17.77
Quick Ratio
0.86 1.48 5.06 2.78 17.77
Cash Ratio
0.41 1.12 4.88 1.23 14.06
Solvency Ratio
1.31 -0.98 -1.33 -0.28 >-0.01
Operating Cash Flow Ratio
-3.29 -3.73 -5.10 -0.38 -3.23
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -1.55M$ -34.54M$ 17.45M$ -160.23M$ 64.72M
Leverage Ratios
Debt-to-Assets Ratio
0.12 0.08 0.03 0.56 0.00
Debt-to-Equity Ratio
-0.88 -0.09 0.12 -0.26 0.00
Debt-to-Capital Ratio
-7.26 -0.10 0.11 -0.34 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 -0.27 0.00
Financial Leverage Ratio
-7.56 -1.09 3.38 -0.46 1.82
Debt Service Coverage Ratio
0.00 0.00 0.00 -17.87 0.00
Interest Coverage Ratio
0.00 0.00 0.00 -17.86 0.00
Debt to Market Cap
0.00 0.00 0.00 0.07 0.00
Interest Debt Per Share
0.02 0.06 0.09 1.08 0.00
Net Debt to EBITDA
-0.15 0.27 0.87 -0.28 19.08
Profitability Margins
Gross Profit Margin
98.05%-203.96%-396.85%100.00%99.68%
EBIT Margin
22.74%-306.54%-594.75%-590.61%-32.43%
EBITDA Margin
25.95%-289.45%-575.74%-571.36%-32.11%
Operating Profit Margin
20.61%-316.72%-594.75%-571.10%-106.09%
Pretax Profit Margin
15.28%-308.05%-582.34%-622.60%-32.43%
Net Profit Margin
15.28%-308.05%-582.34%-622.60%-1.27%
Continuous Operations Profit Margin
15.28%-308.05%-582.34%-622.60%-1.27%
Net Income Per EBT
100.00%100.00%100.00%100.00%3.90%
EBT Per EBIT
74.14%97.26%97.91%109.02%30.57%
Return on Assets (ROA)
122.70%-198.56%-97.01%-84.86%-0.11%
Return on Equity (ROE)
-28.86%216.69%-327.45%38.98%-0.20%
Return on Capital Employed (ROCE)
-4204.26%-431.71%-120.48%-107.01%-9.35%
Return on Invested Capital (ROIC)
-10330.48%-385.25%-117.40%-98.39%-0.37%
Return on Tangible Assets
122.70%-198.56%-97.01%-84.86%-0.12%
Earnings Yield
506.44%-348.33%-88.45%-12.48%-0.23%
Efficiency Ratios
Receivables Turnover
32.17 6.85 0.00 0.00 1.08
Payables Turnover
0.18 28.68 18.85 0.00 0.03
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
76.95 3.06 1.67 0.73 617.30
Asset Turnover
8.03 0.64 0.17 0.14 0.08
Working Capital Turnover Ratio
-18.81 0.54 0.30 0.09 0.22
Cash Conversion Cycle
-1.97K 40.52 -19.37 0.00 -11.91K
Days of Sales Outstanding
11.35 53.25 0.00 0.00 336.80
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
1.98K 12.73 19.37 0.00 12.25K
Operating Cycle
11.35 53.25 0.00 0.00 336.80
Cash Flow Ratios
Operating Cash Flow Per Share
-0.54 -1.45 -2.42 -0.19 -4.09
Free Cash Flow Per Share
-0.54 -1.45 -2.46 -0.30 -4.30
CapEx Per Share
0.00 <0.01 0.03 0.12 0.21
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.01 1.62 1.05
Dividend Paid and CapEx Coverage Ratio
0.00 -487.13 -6.13 -1.62 -19.95
Capital Expenditure Coverage Ratio
0.00 -487.13 -71.71 -1.62 -19.95
Operating Cash Flow Coverage Ratio
-29.42 -24.15 -25.99 -0.19 0.00
Operating Cash Flow to Sales Ratio
-0.43 -3.05 -5.44 -0.77 -1.41
Free Cash Flow Yield
-1409.65%-345.82%-83.80%-2.49%-26.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
0.20 -0.29 -1.13 -8.02 -442.23
Price-to-Sales (P/S) Ratio
0.03 0.88 6.58 49.90 5.60
Price-to-Book (P/B) Ratio
-1.83 -0.62 3.70 -3.12 0.87
Price-to-Free Cash Flow (P/FCF) Ratio
-0.07 -0.29 -1.19 -40.14 -3.79
Price-to-Operating Cash Flow Ratio
-0.07 -0.29 -1.21 -64.86 -3.98
Price-to-Earnings Growth (PEG) Ratio
<0.01 <0.01 -0.02 -0.16 -9.99
Price-to-Fair Value
-1.83 -0.62 3.70 -3.12 0.87
Enterprise Value Multiple
-0.03 -0.03 -0.28 -9.02 1.65
Enterprise Value
-424.89K 1.93M 23.74M 506.70M -14.05M
EV to EBITDA
-0.03 -0.03 -0.28 -9.02 1.65
EV to Sales
>-0.01 0.10 1.59 51.52 -0.53
EV to Free Cash Flow
0.02 -0.03 -0.29 -41.44 0.36
EV to Operating Cash Flow
0.02 -0.03 -0.29 -66.97 0.38
Tangible Book Value Per Share
-0.02 -0.67 0.79 -3.54 15.79
Shareholders’ Equity Per Share
-0.02 -0.67 0.79 -3.90 18.84
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.96
Revenue Per Share
1.26 0.47 0.45 0.24 2.91
Net Income Per Share
0.19 -1.46 -2.59 -1.52 -0.04
Tax Burden
1.00 1.00 1.00 1.00 0.04
Interest Burden
0.67 1.00 0.98 1.05 1.00
Research & Development to Revenue
0.52 3.04 4.97 5.76 0.95
SG&A to Revenue
0.27 1.03 1.98 0.95 0.00
Stock-Based Compensation to Revenue
0.04 0.19 0.16 0.00 0.02
Income Quality
-2.79 0.99 0.93 0.12 0.92
Currency in USD